AU676184B2 - Antiproliferative oligomers - Google Patents

Antiproliferative oligomers Download PDF

Info

Publication number
AU676184B2
AU676184B2 AU46806/93A AU4680693A AU676184B2 AU 676184 B2 AU676184 B2 AU 676184B2 AU 46806/93 A AU46806/93 A AU 46806/93A AU 4680693 A AU4680693 A AU 4680693A AU 676184 B2 AU676184 B2 AU 676184B2
Authority
AU
Australia
Prior art keywords
group
formulae
formula
phenyl
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU46806/93A
Other languages
English (en)
Other versions
AU4680693A (en
Inventor
Steven J Busch
Alan D. Cardin
Masayuki Mano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of AU4680693A publication Critical patent/AU4680693A/en
Application granted granted Critical
Publication of AU676184B2 publication Critical patent/AU676184B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
AU46806/93A 1992-08-19 1993-07-16 Antiproliferative oligomers Ceased AU676184B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93209692A 1992-08-19 1992-08-19
US932096 1992-08-19
PCT/US1993/006693 WO1994004164A1 (en) 1992-08-19 1993-07-16 Antiproliferative oligomers

Publications (2)

Publication Number Publication Date
AU4680693A AU4680693A (en) 1994-03-15
AU676184B2 true AU676184B2 (en) 1997-03-06

Family

ID=25461768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46806/93A Ceased AU676184B2 (en) 1992-08-19 1993-07-16 Antiproliferative oligomers

Country Status (18)

Country Link
US (1) US5460807A (enExample)
EP (1) EP0655922B1 (enExample)
JP (1) JPH08502728A (enExample)
AT (1) ATE148346T1 (enExample)
AU (1) AU676184B2 (enExample)
CA (1) CA2140865A1 (enExample)
DE (1) DE69307899T2 (enExample)
DK (1) DK0655922T3 (enExample)
ES (1) ES2099962T3 (enExample)
GR (1) GR3022937T3 (enExample)
HU (1) HUT69286A (enExample)
IL (1) IL106718A0 (enExample)
MX (1) MX9305011A (enExample)
NO (1) NO950601L (enExample)
NZ (1) NZ254615A (enExample)
TW (1) TW225514B (enExample)
WO (1) WO1994004164A1 (enExample)
ZA (1) ZA935940B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
WO1994026303A1 (en) * 1993-05-13 1994-11-24 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US7611533B2 (en) 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
US7087648B1 (en) * 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
US8198334B2 (en) * 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
AU2005294514A1 (en) * 2004-10-04 2006-04-20 Cellgate, Inc. Polyamine analogs as therapeutic agents for ocular diseases
US11344385B2 (en) 2015-02-23 2022-05-31 Align Technology, Inc. Primer aligner stages for lag issue resolution in low-stage clear aligner treatments

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0467185A2 (en) * 1990-07-09 1992-01-22 The Dow Chemical Company Oligomers, their uses and formulations

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2833744A (en) * 1953-08-27 1958-05-06 Ciba Pharm Prod Inc Polyureas and process of preparing same
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
DE1067212B (de) * 1956-06-04 1959-10-15 Farbenfabriken Bayer Aktiengesellschaft, Leverkusen-Bayerwerk Verfahren zur Herstellung von löslichen Polyharnstoffen
US3164571A (en) * 1959-12-31 1965-01-05 Union Carbide Corp Polyureas from n-phenyl, phenylene biscarbamyl halide and a diamine
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
US4312855A (en) * 1970-11-16 1982-01-26 Colgate-Palmolive Company Compositions containing aminopolyureylene resin
DE2162963C3 (de) * 1971-12-18 1979-02-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 1,4-Diaminobenzol-2,5-disulfonsäure
US3993625A (en) * 1973-05-28 1976-11-23 Toray Industries, Inc. Permselective polymeric membranes of organic polyamide or polyhydrazide
US3978024A (en) * 1973-12-28 1976-08-31 General Electric Company Flame retardant polycarbonate composition
DE2516305A1 (de) * 1975-04-15 1976-10-28 Dynamit Nobel Ag Wasserdispergierbare esterharze
US4756907A (en) * 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4471110A (en) * 1982-08-02 1984-09-11 E. I. Dupont De Nemours And Company Polyamide of disulfonated diamine and permselective membrane thereof
DE3345902A1 (de) * 1983-12-20 1985-08-29 Cassella Ag, 6000 Frankfurt In wasser loesliche polymischester, verfahren zu ihrer herstellung und ihre verwendung
US4863735A (en) * 1985-02-19 1989-09-05 Massachusetts Institute Of Technology Biodegradable polymeric drug delivery system with adjuvant activity
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
US4895660A (en) * 1986-07-14 1990-01-23 The Dow Chemical Company Water-soluble aromatic polyamides and polyureas
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IL95353A (en) * 1989-08-14 1995-01-24 Rhone Poulenc Rorer Int Pharmaceutical preparations containing aromatic polymers

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0467185A2 (en) * 1990-07-09 1992-01-22 The Dow Chemical Company Oligomers, their uses and formulations

Also Published As

Publication number Publication date
AU4680693A (en) 1994-03-15
TW225514B (enExample) 1994-06-21
WO1994004164A1 (en) 1994-03-03
NO950601D0 (no) 1995-02-17
ES2099962T3 (es) 1997-06-01
DK0655922T3 (da) 1997-02-17
IL106718A0 (en) 1993-12-08
DE69307899D1 (de) 1997-03-13
EP0655922B1 (en) 1997-01-29
US5460807A (en) 1995-10-24
ZA935940B (en) 1994-02-07
NO950601L (no) 1995-02-17
DE69307899T2 (de) 1997-06-26
HUT69286A (en) 1995-09-28
ATE148346T1 (de) 1997-02-15
JPH08502728A (ja) 1996-03-26
CA2140865A1 (en) 1994-03-03
GR3022937T3 (en) 1997-06-30
MX9305011A (es) 1994-03-31
NZ254615A (en) 1997-06-24
HU9500492D0 (en) 1995-04-28
EP0655922A1 (en) 1995-06-07

Similar Documents

Publication Publication Date Title
US5460807A (en) Antiproliferative oligomers
US5482925A (en) Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
Wallace Colchicine
US9610256B2 (en) Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer
AU2002246636B2 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
US5516807A (en) Method for treating vascular proliferative disorders following balloon angioplasty
NO20013367L (no) Colchinolderivater som vaskulorskadende midler
CZ20014289A3 (cs) Nové pouľití sloučenin jako antibakteriálních činidel
EP0679081B1 (en) Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
RU2008126305A (ru) Новый пептид
IL85145A (en) Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
CA2190107A1 (en) Compositions for treatment of chronic inflammatory diseases
US20080113960A1 (en) Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor
AU599335B2 (en) Glutamine treatment of catabolic dysfunction
AU675961B2 (en) Antiangiogenic oligomers
CZ20013110A3 (cs) Prostředek pro léčbu arthtritidy
AU649963B2 (en) Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same
ITMI971628A1 (it) Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi
RU2151597C1 (ru) Способ ингибирования пролиферации кератиноцитов
JP2017528508A (ja) 免疫調節における治療剤としてのキヌレニン及び抗原提示細胞（ａｐｃ）の組合せ及び免疫調節におけるその使用のための方法
CA2407132A1 (en) Use of n-heterocyclic substituted salicylates for inhibition of cellular uptake of cystine
JPS61129121A (ja) 抗腫瘍剤
TH25770A (th) การใช้ 3,4 -ไดเฟนิลโครมานในการรักษา?หรือป้องกันโลหิตมีไลโพโปรตีนเกินปกติ,?โรคผนังเส้นโลหิตแดงหนาแข็งกระด้าง ?หรือต่อต้านการเกาะตัวเป็นก้อน